PURPOSE: A noninvasive method for evaluating the infiltration of CD8 METHODS: This human dose-escalation PET imaging study involved eleven patients (lung cancer, 8
gastric carcinoma, 1
esophageal carcinoma, 2). Approximately 150 MBq of [ RESULTS: [ CONCLUSION: The use of [ TRIAL REGISTRATION: NCT05126927 (19 November 2021, retrospectively registered).